Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for minority patients with hard-to-treat stomach and esophageal cancers

NCT ID NCT07554521

Recruiting now Disease control Sponsor: BeOne Medicines Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 4 times

Summary

This study is testing a drug called tislelizumab combined with chemotherapy as a first treatment for people with advanced stomach or esophageal cancer that cannot be removed by surgery or has spread. It focuses on racial and ethnic minority groups in the US, including Black, Hispanic, and Native American individuals. The goal is to see if the combination is safe and helps shrink or control the cancer, but it is not expected to be a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED GASTROESOPHAGEAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

esophageal squamous cell carcinoma gastric adenocarcinoma gastroesophageal adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED GASTROESOPHAGEAL ADENOCARCINOMA ADVANCED UNRESECTABLE GASTRIC ADENOCARCINOMA ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bioresearch Partners Holding Hialeah Hospital

    RECRUITING

    Hialeah, Florida, 33013-3804, United States

  • Florida Clinical Trials Group Plantation

    RECRUITING

    Plantation, Florida, 33322, United States

  • Florida Clinical Trials Group Tamarac

    RECRUITING

    Tamarac, Florida, 33321, United States

  • Gabrail Cancer Center Research

    RECRUITING

    Canton, Ohio, 44718-2566, United States

  • Los Angeles Cancer Network

    RECRUITING

    Los Angeles, California, 90017-4803, United States

  • Washington University School of Medicine

    RECRUITING

    St Louis, Missouri, 63110-1010, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.